Influenza and Pneumococcal vaccinations for Covid19 Severity and Other Perspectives

This book deals with the benefits of influenza and pneumococcal vaccinations in the Covid19 pandemic. From the beginning of the 1st Covid19 wave the role of influenza and pneumococcal vaccines have been discussed though not highlighted. However, they are not substitutes or replacement for Covid19 vaccines. There are good number of people who have not taken Covid19 vaccinations for many reasons worldwide. It could be logistic or personal reasons. Also pregnant women, old and very young people are reluctant to take Covid 19 vaccines. Some people develop allergic reactions to the first dose of Covid19 vaccination. The mechanisms of these 2 vaccines (Influenza and pneumococcal) are different and primarily improve the innate immunity which can supervise and monitor antigenic subversions in SARS CoV2. Both influenza and pneumococcal vaccines are time-tested and available in routine clinical practice for more than 20 years. In the past these vaccines were used in young and old, immunocompromised, pregnancy and individuals with various co-morbidities.